We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+7.31%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$329B
AUM Growth
+$18.7B
Cap. Flow
+$4.79B
Cap. Flow %
1.46%
Top 10 Hldgs %
17.35%
Holding
3,654
New
108
Increased
2,088
Reduced
988
Closed
104

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$1.91B
2
UPS icon
United Parcel Service
UPS
+$1.86B
3
CVX icon
Chevron
CVX
+$1.72B
4
BX icon
Blackstone
BX
+$904M
5
F icon
Ford
F
+$722M

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$1.64B
2
PRU icon
Prudential Financial
PRU
+$553M
3
GPC icon
Genuine Parts
GPC
+$543M
4
CMI icon
Cummins
CMI
+$538M
5
HIG icon
Hartford Financial Services
HIG
+$376M

Sector Composition

Rank Sector Weight
1 Technology 21.33%
2 Healthcare 13.03%
3 Financials 11.86%
4 Consumer Discretionary 9.84%
5 Industrials 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DRIO icon
3376
DarioHealth
DRIO
$70.9M
$42.4K ﹤0.01%
515
DMTK
3377
DELISTED
DermTech, Inc. Common Stock
DMTK
$42.4K ﹤0.01%
+11,512
New +$48.5K
ATIP
3378
DELISTED
ATI Physical Therapy, Inc.
ATIP
$41.8K ﹤0.01%
3,288
IMA
3379
ImageneBio Inc
IMA
$63M
$41.6K ﹤0.01%
1,006
GORO icon
3380
Goldgroup Mining Inc.
GORO
$157M
$41.5K ﹤0.01%
39,537
SPRO icon
3381
Spero Therapeutics
SPRO
$67.7M
$41.4K ﹤0.01%
28,565
SDC
3382
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$40.9K ﹤0.01%
95,034
GAN
3383
DELISTED
GAN Ltd
GAN
$40.6K ﹤0.01%
31,476
STIM icon
3384
Neuronetics
STIM
$138M
$40.3K ﹤0.01%
13,837
MAMA icon
3385
Mama's Creations
MAMA
$857M
$39.9K ﹤0.01%
+21,021
New +$39K
LNAI
3386
Lunai Bioworks
LNAI
$8.8M
$39.7K ﹤0.01%
543
-94
-15% -$8.27K
PHUN icon
3387
Phunware
PHUN
$43.1M
$39.4K ﹤0.01%
1,110
DTIL icon
3388
Precision BioSciences
DTIL
$180M
$38.6K ﹤0.01%
1,709
MNOV icon
3389
MediciNova
MNOV
$65.5M
$38.5K ﹤0.01%
17,843
SNCE
3390
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$38.5K ﹤0.01%
6,840
BDSX icon
3391
Biodesix
BDSX
$220M
$38.4K ﹤0.01%
+1,031
New +$42.3K
WWR icon
3392
Westwater Resources
WWR
$52.4M
$38.3K ﹤0.01%
34,475
CVM icon
3393
CEL-SCI Corp
CVM
$20.3M
$38.2K ﹤0.01%
549
ZEV
3394
DELISTED
Lightning eMotors, Inc.
ZEV
$37.9K ﹤0.01%
6,621
+2,320
+54% +$27K
HMPT
3395
DELISTED
Home Point Capital, Inc Common Stock
HMPT
$37.9K ﹤0.01%
19,614
NAGE
3396
Niagen Bioscience
NAGE
$271M
$37.7K ﹤0.01%
24,667
CTMX icon
3397
CytomX Therapeutics
CTMX
$675M
$37.5K ﹤0.01%
24,817
-17,404
-41% -$39.3K
CTM icon
3398
Castellum
CTM
$68M
$37.4K ﹤0.01%
34,318
REFR icon
3399
Research Frontiers
REFR
$14M
$37.4K ﹤0.01%
21,870
IMUX icon
3400
Immunic
IMUX
$190M
$37.3K ﹤0.01%
+2,500
New +$46.4K

Similar funds

Charles Schwab's Q1 2023 Portfolio in Review

As of Q1 2023, Charles Schwab held 3,654 positions worth $329B, up 6% from $310B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Charles Schwab's Q1 2023 filing shows 108 new, 2,088 increased, 988 reduced and 104 closed positions. Its largest new stake was GE HealthCare: 1,875,333 shares worth $154M. The largest sale was IBM, an estimated $1.64B.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Charles Schwab's largest Q1 2023 buy was GE HealthCare: 1,875,333 shares worth $154M.
  • Charles Schwab added most to AbbVie in Q1 2023, an estimated $1.91B increase.
  • Charles Schwab's biggest Q1 2023 reduction was IBM, cutting an estimated $1.64B.
  • Charles Schwab fully exited STORE Capital Corporation in Q1 2023, selling an estimated $100M.
  • Charles Schwab's ten largest holdings make up 17% of its $329B portfolio in Q1 2023.
  • Charles Schwab opened 108 new positions and closed 104 in Q1 2023.
  • Charles Schwab's portfolio value rose 6% quarter-over-quarter to $329B.

Based on Charles Schwab's 13F filing for Q1 2023, filed 12 May 2023.